Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy

Benzer Materyaller

• Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem
  Yazar:: Cirillo, Iolanda, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients
  Yazar:: Samtani, Mahesh N., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients
  Yazar:: Nandy, Partha, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age
  Yazar:: Cirillo, Iolanda, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
  Yazar:: Jang, Soo Min, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)